This inventor holds 1 USPTO granted patent. Top assignees: Kabushiki Kaisha Yakult Honsha, National Cerebral and Cardiovascular Center. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 215 
1 out of 51 
Years Active: 2025
Title: Keisuke Taniguchi: Innovator in Tumor Immunotherapy
Introduction
Keisuke Taniguchi is a notable inventor based in Minato-ku, Japan. He has made significant contributions to the field of tumor immunotherapy, particularly through his innovative patent that enhances immune response.
Latest Patents
Taniguchi holds a patent for an "Antitumor effect potentiator." This invention serves as an activator suitable for immune response in tumor immunotherapy using an immune checkpoint inhibitor. The agent is designed to potentiate the antitumor effect of an immune checkpoint inhibitor and may contain a probiotic and a prebiotic as active ingredients.
Career Highlights
Throughout his career, Taniguchi has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and Yakult Honsha Co., Ltd. His work in these institutions has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Taniguchi has collaborated with notable colleagues, including Kenji Kangawa and Takashi Nojiri. Their combined expertise has contributed to advancements in immunotherapy and related research.
Conclusion
Keisuke Taniguchi's work in tumor immunotherapy exemplifies the impact of innovative thinking in medicine. His patent and collaborations highlight the importance of research in enhancing treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile